Angiodynamics, Inc. (ANGO) fundamentals score
AngioDynamics is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing and selling products and technologies which aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses.
Surgical & Medical Instruments & Apparatus · Healthcare · Listed on NASDAQ
Overall: 5.5 out of 10, Mixed fundamentals
- Growth: 3.6/10
- Profitability: 4.2/10
- Financial health: 7.1/10
- Earnings quality: 8.7/10
- Valuation: 5.7/10
Scores are calculated from Angiodynamics, Inc.’s SEC filings, using the 12 months through 2026-08. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10